Sort by 'likes'
Enhancing Diversity in Cancer Clinical Trials
For decades, there has been an alarming lack of diversity in cancer clinical trials. Why does this happen, what can we do about it and how can we increase minority representation in these potentially life-saving trials are some of the…
Myeloma Survivors Jim & Kathleen Bond Share their Myeloma Story
On this On-Air Myeloma Support Group Meet, myeloma survivors Jim Bond & Kathleen Bond share their myeloma story and give out tips on surviving everyday challenges myeloma brings along.
Goals and challenges of developing a patient focused myeloma center of excellence
The multiple myeloma treatment field has undergone several changes over the past 10-20 years. The average overall survival has changed from 1-3 years to 10-20 years. Yet, there is no established curative therapy for multiple myeloma. However, advanced monitoring with…
The New Optimism of Combination Therapies in Multiple Myeloma Treatment.
Clinical trials of new combination therapies are showing promising results and can be a game changer in myeloma treatment - Combining standard drugs with monoclonal antibodies, t-cell therapies with stem cell transplants, myeloma vaccine combinations and more. buy nolvadex online…
HIFU & Focal Therapy for Prostate Cancer
"Decades after lumpectomy became a standard option for women with breast cancer, men are seeking a similarly targeted approach to prostate cancer, one that gets rid of the tumor while preserving the organ. Now, an array of technologies is enabling…